Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases.
about
Synaptic plasticity: multiple forms, functions, and mechanismsMetabotropic glutamate receptors in the basal ganglia motor circuitImpaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient miceImpaired spatial working memory and altered choline acetyltransferase (CHAT) immunoreactivity and nicotinic receptor binding in rats exposed to intermittent hypoxia during sleepStriatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystoniaMetabotropic glutamate receptors: from the workbench to the bedside.Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse.Retinoic Acid Signaling: A New Piece in the Spoken Language Puzzle.Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signalingConvergent evidence for abnormal striatal synaptic plasticity in dystonia.Cooperative signaling between homodimers of metabotropic glutamate receptors 1 and 5Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystoniaMigraine attacks the Basal Ganglia.In vivo Electrochemical Biosensor for Brain Glutamate Detection: A Mini Review.Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements.Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Therapeutic implications of the mGluR theory of fragile X mental retardation.Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.Cocaine and Amphetamine Induce Overlapping but Distinct Patterns of AMPAR Plasticity in Nucleus Accumbens Medium Spiny Neurons.Glutamate transporters in the biology of malignant gliomasTherapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.NMDARs in neurological diseases: a potential therapeutic target.Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteomemGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias.mGluR4-containing corticostriatal terminals: synaptic interactions with direct and indirect pathway neurons in mice.Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primatesSubstance P depolarizes striatal projection neurons and facilitates their glutamatergic inputs.Inositol 1,4,5-triphosphate drives glutamatergic and cholinergic inhibition selectively in spiny projection neurons in the striatum.Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum.Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.Ammonia-induced deficit in corticostriatal long-term depression and its amelioration by zaprinast.Ethanol disrupts the mechanisms of induction of long-term potentiation in the mouse nucleus accumbens.Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease?
P2860
Q28242702-8F141805-827E-42FF-B02C-DD5C33541146Q28280931-E621452B-C19A-405C-A178-EF8690F8261CQ28513036-2E402165-4817-4B84-95B8-34E8CC67DB84Q28579395-D53987DF-AE8A-4CFF-9425-ABEE556DBE72Q28648007-DF7BF64F-30EC-4FC0-9747-2B410DAF6681Q30448778-DFF2578A-8F4B-4155-AC03-D39619B7C4BFQ30465586-7389E42A-A0A1-414B-8C4E-8EB2AF489551Q30497841-01958320-8480-48ED-BD5F-095E4EB4994DQ33362024-8898E511-8303-448C-A87D-1D7F3D095B61Q33428476-0CACB0E9-70F4-452C-AC19-1BE67DA21DC0Q33756951-FE438C25-87DC-4F97-8BC0-68D95D2C73B6Q34360070-A9B9A022-6A5B-4E44-B345-60A9FAD606CDQ34362073-1F73E655-A513-4FF3-8420-9CA3C08E1F48Q35147361-E9F461D2-E042-475A-9AFC-76E09FA5AC95Q35338284-D6425A9A-E498-4E50-9E20-77205919E33FQ35518399-743950B6-596B-4C3B-B46B-E3009BE1BE86Q35932567-5167397F-68BC-4D95-82DC-629FFDD03D1FQ36020776-58F3B826-9983-4B2D-8EFA-49FB95CC3A81Q36228104-62A7E644-5175-4FD9-8733-62967E372A2FQ37384351-D342C061-270A-449A-84A7-16E1738CFE3AQ37458215-703FBA96-C3F0-4373-A178-3C1A9AC4835AQ37722469-4A8734D9-0088-4BE7-AC1E-CA86B6EF8498Q38092819-390202C0-6F81-4DAB-A8A8-DDC060994682Q38232734-B79333D2-8215-4403-BAFC-DBF8629FA86EQ38512252-9EB670DE-6157-493F-ADA2-BFEC2EA477B6Q38660240-9384DCC7-EE06-4DA2-BCA5-B1755109F26FQ40035243-879D8DDC-8C21-4FA5-9B9B-A8E6CB2A8482Q40313187-5F69BB20-1A04-4F91-95B9-F27F3BC07F9FQ42174379-CAAA506A-F5C6-4B6C-809E-4C52B356CE29Q42177230-8B24A6D9-9339-4945-86A6-283585EECAD9Q42434375-9D9A9D74-D1FC-48C3-9F41-0B6D37E2CFF3Q42525242-9EC455C9-F804-4808-92C0-DB051B9D3ABEQ43247272-0308CB93-6E82-4973-98DD-D0AF78F2CA3AQ45299599-F46B335E-73C6-49A0-9F44-0048C8808F06Q47766445-B220538E-DE0A-4763-90C4-39DC6B50DF24Q48243272-5EDE1339-DE42-43D1-8336-A3A95CCA80FBQ48491950-E464F8FC-90EA-43BE-89C3-DCAFB6647D2EQ48536490-A72B61D7-1E42-43A0-858B-B652507B8F1BQ48617548-7DEF47CE-BCEB-4B0D-8FB9-E782587A0867Q51750611-BA1886F1-BD9A-46B3-B02E-547509C1E781
P2860
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Metabotropic glutamate recepto ...... ons for neurological diseases.
@ast
Metabotropic glutamate recepto ...... ons for neurological diseases.
@en
type
label
Metabotropic glutamate recepto ...... ons for neurological diseases.
@ast
Metabotropic glutamate recepto ...... ons for neurological diseases.
@en
prefLabel
Metabotropic glutamate recepto ...... ons for neurological diseases.
@ast
Metabotropic glutamate recepto ...... ons for neurological diseases.
@en
P2093
P1476
Metabotropic glutamate recepto ...... ons for neurological diseases.
@en
P2093
Antonio Pisani
Giorgio Bernardi
Paolo Calabresi
Paolo Gubellini
P304
P356
10.1016/J.PNEUROBIO.2004.09.005
P577
2004-12-01T00:00:00Z